References
- 김영웅, 안소신, 홍원표. 혈액안의 기초적인 이해와 치료방법의 동향. BioWave, 7(17), ISSN 1598-8767, 2005
- Milligan, D. W., Grimwade, D., Cullis, J. O., Bond, L., Swirsky, D., Craddock, C, et al. Guidelines on the management of acute myeloid leukemia in adults. British Journal of Hematology, 135, 450-474, 2006 https://doi.org/10.1111/j.1365-2141.2006.06314.x
- 최수미, 이동건, 박윤희, 김유진, 김희제, 이 석, 최정현, 유진홍, 김동욱, 이종욱, 민우성, 신완신, 김춘추. 급성 백혈병 환자의 감염양상 : 관해유도 및 재관해유도 화학요법 환자군의 비교. 감염과 화학요법, 35(2), 78-85, 2003.
- Moschovi, M., Trimis, G., Apostolakou, F., Papassotiriou, I., & Tzortzatou-Stathopoulou, F, Serum lipid alterations in acute lymphoblastic leukemia of childhood. Journal Pediatric Hematology Oncology, 26(5), 289-93. 2004 https://doi.org/10.1097/00043426-200405000-00006
- 김형섭. 내과학, 혈액종양. 서울: 고려의학, 129-147, 2003.
- 김권범, 정희진, 김병수, 신상원, 김열흥, 김우주, 김민자, 김준석, 박승철. 급성 백혈병 환자에서 감염증의 양상 및 예후인자에 관한 연구, 감염, 30(3), 243-250, 1998
- 최재혁, 이구, 오현아, 강희정, 이재련, 이경희, 현명수, 류헌모. 급성 골수성 백혈병 환자의 관해유도 화학요법 후 과립구 집락촉진인자의 효과. 대한혈액학회지, 37(1), 17-23, 2002.
- 장은재, 홍정임. 골수이식을 받은 혈액질환 환자의 영양 상태에 따른 치료효과에 관한 연구. 생활과학연구, 7, 99-112, 2002.
- 홍정임, 장은재. 동종 골수이식을 받은 급성골수성백혈병 환자의 영양상태와 생착일수에 관한 연구. 대한지역사회영향학회지, 7(4), 578-584, 2002.
- 부산대학교 진단검사의학과. 진단검사의학과 검사의뢰지침서, 2차 개정판, 부산: 우주문화사, 2007.
- Tsutomu, K., Noriyuki, K., Hirofumi, M., Masashi, A., & Toru, W. Standardization of the Body Surface Area(BSA) formula to calculate the dose of anticancer agent in Japan. Japanese Journal of Clinical Oncology, 33(6), 309-313, 2003. https://doi.org/10.1093/jjco/hyg062
- Hiza, H. A., Pratt, C, Mardis, A. L., & Anand, R. Body Mass Index and health. A Publication of the USDA center for Nutrition Policy and Promotion insight 16, 2000.
- Lyman, G. H., Lyman, C. H. & Agboola, O. Risk models lor predicting chemotherapy-induced neutropenia. The Oncologist, 427-437, 2005
- 장세리, 김희선, 이영호. 항암 화학요법 중인 소아암 환자의 영양 평가 및 식이 관리. 대한소아소화기영양학회지, 2(2), 204-210, 1999.
- 이동곤, 노영일, 문경래. 입원 환아의 영양상태 평가. 대한소아소화기영양학회지, 4(1), 83-91, 2001.
- Milligan, D. W., Grimwade, D., Cullis, J. O., Bond, L., Swirsky, D., Craddock, C., et al., Guidelines on the management of acute myeloid leukemia in adults. British Journal of Hematology, 135, 450-474, 2006. https://doi.org/10.1111/j.1365-2141.2006.06314.x
- Aslani, A., Smith, R. C., Allen, B. J., Pavlakis, N., & Levi, J. A. The predictive value of body protein for chemotherapy-induced toxicity. American Cancer Society, 88(4), 796-803, 2000.
- Morrison, V. A., Picozzi, V., Scott, S., & Pohlman, B. E.. The impact of age on delivered dose intensity and hospitalizations for fobrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis. Clinical Lymphoma, 2, 47-56, 2001. https://doi.org/10.3816/CLM.2001.n.011
- Celebi, H., Akan, H., AkCaglayan, E., Ustun, C. & Arat, M. Febrile neutropenia in allogeneic and autologous perpheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant, 26(2), 211-214, 2000. https://doi.org/10.1038/sj.bmt.1702503
- Morrison, V. A., Picozzi, Y., Scott, S., & Pohlman, B E. The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis. Clinical Lymphoma 2, 47-56, 2001. https://doi.org/10.3816/CLM.2001.n.011
- Kuderer, N. M., Dale, D. C., Crawford, J. & Lyman, G. H. The impact of febrile neutropenia in hospotalized cancer patients: morbidity, mortality, and cost. Process American Society Clinical Oncology, 23, 259, 2004.
- Morrison, V. A., Caggiano, Y., Fridman, M., & Delgado, D. J. A model to predict chemotherapy-related severe or febrile neutropenia in cycle one among breast cancer and lymphoma patients. Process American Society of Clinical Oncology, 23. 742, 2004
- Wolff, D. A., Crawford, J., Dale, D. C., Poniewierski, M. S., & Lyman, G. H. Risk of neutropenic complications based on aprospective nationwide registry of cancer patients initiating systemic chemotherapy. The Journal of Supportive Oncology, 3(2), supplement 1, 56-57, 2005.
- Crawford, J., Wolff, D. A., Culakova, E., Poniewierski, M. S., Selby, C., Dale, D. & Lyman, G. H. First-cycle risk of severe and febrile neutropenia in cancer patients receiving systemic chemotherapy results from a prospective nationwide study. The Journal of Supportive Oncology. 3(2). supplement 1, 52-53, 2005.